Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Frontiers in Pediatrics|December 4, 2024
Case Report: Nephrocalcinosis in an infant due to vitamin-D food supplement overdoseCarla Pizzini, Andrea Ossato, Nicola Realdon, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|May 3, 2026
Effectiveness of Patent Foramen Ovale Occlusion Devices Versus Medical Therapy: An Indirect Comparison Based on Reconstructed Individual Patient DataMelania Rivano, Roberto Brunoro, Marco Cesca, et al.
Cancers|April 13, 2023
Progression-Free and Overall Survival of First-Line Treatments for Advanced Renal Cell Carcinoma: Indirect Comparison of Six Combination RegimensAndrea Ossato, Daniele Mengato, Marco Chiumente, et al.
Journal of Chemotherapy (Florence, Italy)|October 21, 2024
Comparative efficacy of chemo-immunotherapy combination regimens in the frontline setting for NSCLC based on reconstructed patient dataAndrea Ossato, Luna Del Bono, Lorenzo Gasperoni, et al.
Cancers|February 10, 2024
Efficacy of Immune Checkpoint Inhibitors vs. Tyrosine Kinase Inhibitors/Everolimus in Adjuvant Renal Cell Carcinoma: Indirect Comparison of Disease-Free SurvivalAndrea Ossato, Lorenzo Gasperoni, Luna Del Bono, et al.
Cancer Medicine|August 3, 2022
Immune checkpoint inhibitors as first line in advanced melanoma: Evaluating progression-free survival based on reconstructed individual patient dataAndrea Ossato, Vera Damuzzo, Paolo Baldo, et al.
Current Oncology (Toronto, Ont.)|January 24, 2025
Treatment Options for Advanced Non-Small Cell Lung Cancer After Failure of Previous Immune Checkpoint Inhibitors and Chemotherapy: Meta-Analysis of Five Randomized Controlled TrialsAndrea Messori, Andrea Ossato, Lorenzo Gasperoni, et al.
European Journal of Hospital Pharmacy : Science and Practice|July 28, 2021
Comparison of medium-term adverse reactions induced by the first and second dose of mRNA BNT162b2 (Comirnaty, Pfizer-BioNTech) vaccine: a post-marketing Italian study conducted between 1 January and 28 February 2021Andrea Ossato, Roberto Tessari, Carlotta Trabucchi, et al.
Cureus|September 29, 2022
The "One-to-Many" Survival Analysis to Evaluate a New Treatment in Comparison With Therapeutic Alternatives Based on Reconstructed Patient Data: Enfortumab Vedotin Versus Standard of Care in Advanced or Metastatic Urothelial CarcinomaAndrea Messori, Melania Rivano, Luca Cancanelli, et al.
Neurotoxicity Research|June 25, 2017
The Cathinones MDPV and α-PVP Elicit Different Behavioral and Molecular Effects Following Acute ExposureGiuseppe Giannotti, Isabella Canazza, Lucia Caffino, et al.
Pageof 4